https://www.newswire.ca/news-releases/cosira-study-data-presented-at-acc14-confirms-the-neovasc-reducertm-improves-functional-capabilities-in-refractory-angina-patients-514010531.html
COSIRA Study Data Presented at ACC.14 Confirms the Neovasc Reducer(TM) Improves Functional...
/CNW/ - Neovasc Inc. (TSXV: NVC) today reported that final data from its COSIRA trial assessing the efficacy and safety of the Neovasc ReducerTM, a novel...